Special Issue "A Systematic Development Method for Rational Drug Design"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Physical Chemistry, Theoretical and Computational Chemistry".
Deadline for manuscript submissions: closed (28 February 2011)
Dr. Dooil Kim
Korea Research Institute of Bioscience and Biotechnology, Systems Microbiology Research Center, Deajeon 305-806, South Korea
Fax: +82 42 860 4597
Interests: bioinformatics; database development; comparative genomics; cheminformatics; molecular modeling; computer aided drug design
Traditionally drug discovery used to be a trial and error process, where chemical compounds from plant and other natural extracts were proposed for action against a disease and then tested for the compounds’ effectiveness in curing the disease on animal or tissue based models. Drug discovery process has now evolved into a much more scientific and rational process due to better understanding of the biological processes and the underlying chemistry, owing to the progress made due to advances in high throughput experimental techniques and availability of high performance computation resources. The process has matured to the stage where drugs are designed now rather than being discovered.
Dr. Dooil Kim
- drug design
- machine learning
- data mining
- high throughput screening